³í¹®) Serial ctDNA testing with tumor naïve, small-sized NGS panel: Clinical utility in 1 detecting minimal residual disease and early recurrence in ovarian cancer ¿¬¼¼¾Ïº´¿ø ºÎÀξϼ¾ÅÍ ÀÌÁ¤À± ±³¼ö, ±èÀ¯³ª °»ç, ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç À̽ÂÅ ±³¼ö, ½É¿¹Àº ¿¬±¸¿ø ¿¬±¸ÆÀ